+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Agricultural Biotechnology - Global Strategic Business Report

  • PDF Icon

    Report

  • 263 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338408

Global Agricultural Biotechnology Market to Reach $88.9 Billion by 2030

The global market for Agricultural Biotechnology estimated at US$47.7 Billion in the year 2023, is projected to reach a revised size of US$88.9 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record 9.3% CAGR and reach US$35.6 Billion by the end of the analysis period. Growth in the Tissue Culture segment is estimated at 8.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $14.2 Billion, While China is Forecast to Grow at 7.5% CAGR

The Agricultural Biotechnology market in the U.S. is estimated at US$14.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 6.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Report Features

  • Full access to influencer engagement stats
  • Access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 17 Featured) -

  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Prelude
  • Recent Market Activity
  • Widening Gap between Food Demand and Production Raises Significance of Agricultural Biotechnology
  • Opportunity Indicators in a Nutshell
  • Transgenic Seeds & Crops Spearhead Growth in the Agricultural Biotech Market
  • Highlights
  • Significant Benefits of GM Crops Augur Well for Market Growth
  • Biotech Cropland Worldwide - An Overview
  • Developed Regions Lead GM Crop Cultivation, Developing Regions Promise Future Growth
  • Barriers to Expansion of Biotechnology in Agriculture Industry
  • Bt. Cotton: Adoption All Set to Increase Further in the Coming Years
  • Robust R&D Pipeline to Play a Pivotal Role in Adoption of Bt. Cotton
  • Challenges Hindering Wider Adoption of GM Crops
  • Biopesticides: Natural Attributes Spur Global Demand
  • Developed Countries: Leading Consumers of Biopesticides
  • Biopesticides - A Crucial Component for Implementing Integrated Pest Management
  • Explosive Growth in Organic Farming Augurs Well for Biopesticides Market
  • Lack of Familiarity & Negative Perceptions Hinder Uptake of Biopesticides among Farmers
  • Biopesticide Regulations in the US and Europe
  • Agricultural Biotechnology - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • ADAMA Agricultural Solutions Ltd. (Israel)
  • BASF SE (Germany)
  • Bayer CropScience AG (Germany)
  • Certis USA LLC (USA)
  • Dow AgroSciences, LLC (USA)
  • Mycogen Seeds (USA)
  • DuPont Pioneer (USA)
  • Marrone Bio Innovations, Inc. (USA)
  • Monsanto Company (USA)
  • Performance Plants, Inc. (Canada)
  • Syngenta AG (Switzerland)
  • Valent BioSciences Corporation (USA)
3. MARKET TRENDS & DRIVERS
  • Food Security - An Opportunity Generator
  • Rising Demand for Biofuels: Positive Implications for GM Crops Market
  • Introduction of Bt Cotton and Bt Brinjal Enhance Agricultural Production
  • IRRI Working to Develop Stress-Tolerant Rice Variants
  • Advent of Insect Resistant Crops Fuel Growth for Agriculture Industry
  • Global Reservations Persist in Acknowledging Benefits of GM Crops
  • Integration of Biotechnology and IT Revolutionizes Agriculture Sector
  • Development of New Herbicide-Tolerant Traits Gathers Steam
  • Advanced Farming Techniques for Increasing Agricultural Yields
  • Misuse of Indigenous Resources of Developing Countries: A Cause of Concern
  • Educating Consumers - Need of the Hour
  • Synthetic Biology - A Brief Review
  • Synthetic Biology: Prediction Becoming Reality
  • Biostimulants: Growing Interest in Organic Food to Propel Growth
  • Need for Sustainable Agriculture - Key Growth Driver
  • Lack of Thorough Research Impedes Growth in Biostimulants Market
  • Need for Paradigm Shift in Grower Mindset Regarding Biostimulants
  • The Road Ahead
  • Sales of Non-GMO products to Register Impressive Growth
  • Public-Private Sector Partnerships Gain Importance
  • Protection of Intellectual Property Demands High Attention
  • Challenges Aplenty for Agricultural Biotechnology in Developing Nations
  • Dearth of Competent Leadership
  • Insufficient Financial Support for R&D
  • Lack of Scientific and Technological Infrastructure
  • Insufficient Expertise and Human Resources
  • Safety Issues
  • Ethical Issues
  • Lack of Regulatory Framework
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Tissue Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Synthetic Biology-enabled Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 28: World Agricultural Biotechnology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: USA Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: USA 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: USA Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: USA 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: Canada 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Canada 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
JAPAN
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Japan 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Japan 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
CHINA
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: China Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: China 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: China Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: China 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
EUROPE
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: Europe 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: Europe 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
FRANCE
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: France Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: France 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: France Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: France 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
GERMANY
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: Germany 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: Germany 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: Italy 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: Italy 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: UK Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: UK 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: UK Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: UK 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: Rest of Europe 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Agricultural Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Asia-Pacific 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 99: Rest of World Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Rest of World 16-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2014, 2023 & 2030
  • Table 101: Rest of World Recent Past, Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 102: Rest of World Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 103: Rest of World 16-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation

Table Information